Inovio (INO) falls 1.51% on September 30 at moderate volumes

0

Today Inovio Pharmaceuticals Inc Inc (NASDAQ: INO) stock fell $ 0.11, down 1.51%. Inovio opened at $ 7.30 before trading between $ 7.44 and $ 7.15 throughout the Thursday session. The activity caused Inovio’s market cap to drop to $ 1,506,155,375 on 3,092,465 shares – below its 30-day average of 3,747,698.

About Inovio Pharmaceuticals Inc

INOVIO is a biotechnology company focused on rapidly bringing to market precisely engineered DNA drugs to treat and protect people from infectious diseases, cancer, and HPV-related diseases. INOVIO is the first and only company to have clinically proven that a DNA drug can be delivered directly into the body’s cells via a proprietary intelligent device to generate a robust and tolerable immune response. INOVIO’s lead immunotherapy candidate, VGX-3100, currently in phase 3 trials for precancerous cervical dysplasia, has confirmed high-risk HPV-16 and / or HPV-18 in a phase 2b clinical trial. High-risk HPV is responsible for 70% of cervical cancer, 91% of anal cancer, and 69% of vulvar cancer. Programs against HPV-related cancers and a rare HPV-related disease, recurrent respiratory papillomatosis (RRP), are also being developed; non-HPV-related cancers glioblastoma multiforme (GBM) and prostate cancer; and DNA vaccine development programs for coronavirus infectious diseases associated with COVID-19 diseases and MERS, Lassa fever, Ebola and HIV. Partners and employees include Advaccine, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA) / Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) / Department of Defense (DoD), HIV Vaccines Trial Network, International Vaccine Institute (IVI), Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron, Richter-Helm BioLogics, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. INOVIO is also the proud recipient of the “Women on Boards” 2020 award, which recognizes companies with more than 20% women on their board of directors.

Visit Inovio Pharmaceuticals Inc’s profile for more information.

The daily fix

Beyond Meat Inc’s (Nasdaq: BYND) meatless chicken tenders will be available for purchase in select grocery stores nationwide starting next month, the artificial meat company said on Monday.

The Federal Aviation Administration (FAA) wants U.S. passenger airlines to do more to cope with the increase in incidents involving recalcitrant or violent passengers.

Athletes competing to represent the United States at the 2022 Olympic Winter Games in Beijing must be vaccinated against COVID-19, the United States Olympic and Paralympic Committee (USOPC) said.

Via the Nasdaq Stock Exchange

The Nasdaq Stock Market is a leading global provider of trading data and services, as well as the listing of stocks and options. Nasdaq is the world’s leading exchange for option volumes and is home to the five largest US companies – Apple, Microsoft, Amazon, Alphabet and Facebook.

For more information about Inovio Pharmaceuticals Inc. and to keep up with the latest company updates, please visit the company’s profile page here: Inovio Pharmaceuticals Inc. Profile For more financial market news, visit Equities News. Also, don’t forget to sign up for the Daily Fix to get the best stories in your inbox 5 days a week.

Sources: The chart is provided by TradingView based on 15 minute delayed prices. All other data will be made available by IEX Cloud starting at 8:05 p.m. ET on the day of publication.

DISCLOSURE:
The views and opinions expressed in this article are those of the authors and do not reflect the views of equities.com. Readers should not regard statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Beyond Meat launches meat-free chicken offerings in grocery stores in October


President Biden welcomes leaders from India, Japan and Australia to the first “Quad” summit on Friday

Some Chinese banks are no longer providing new loans to real estate developers amid fears of Evergrande

Iowa’s Senator Chuck Grassley is aiming for his eighth term

House Special Committee summons for four Trump allies in the U.S. Capitol Riot investigation

CDC Endorses COVID-19 Vaccine Booster Vaccinations for Millions of Elderly and Vulnerable People

Semiconductor shortages will cost the global auto industry $ 210 billion in sales in 2021

U.S. Olympic athletes must be vaccinated against COVID-19 for the Beijing Winter Games

Share.

Comments are closed.